Role of BMP Signaling in the Aging Brain R01 AG054429
BMP 信号传导在大脑衰老中的作用 R01 AG054429
基本信息
- 批准号:10121093
- 负责人:
- 金额:$ 35.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2022-05-31
- 项目状态:已结题
- 来源:
- 关键词:AD transgenic miceAddressAgeAge-MonthsAgingAllelesAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloid beta-ProteinAmyloid depositionApolipoprotein EAstrocytesBehavioralBiochemicalBiologicalBrainCRISPR/Cas technologyCalciumCell DeathCognitionCognitive deficitsDevelopmentDiseaseEtiologyExerciseExhibitsFunctional disorderGenesGenotypeGlutamatesGoalsGrantHeterogeneityHeterozygoteHippocampus (Brain)HumanImpaired cognitionImpairmentIndividualInjectionsIntraventricular InfusionIonophoresKnowledgeLeadLearningLinkMediatingMemoryMorphologyMusNeuritesNeuronsPathologicPathologyPatientsPerformancePhenotypePhosphotransferasesPredispositionProcessProtein IsoformsRisk FactorsRodentRoleSignal PathwaySignal TransductionStructureSynapsesSystemTimeToxic effectTransgenic Organismsadeno-associated viral vectorage effectage relatedagedaging brainaxonopathybone morphogenetic protein 4cerebral atrophycognitive taskdentate gyrusexcitatory neuronfunctional declinegene productin vivoinduced pluripotent stem cellinhibitor/antagonistinsightmouse modelneurogenesisneuron lossneuronal survivalnonhuman primateoverexpressionp38 Mitogen Activated Protein Kinasepreservationpreventstem cellstau Proteinstau phosphorylationtau-1toolβ-amyloid burden
项目摘要
Aging is the leading risk factor for developing sporadic Alzheimer’s disease (sAD) suggesting that
the aging process is linked to the pathophysiology of the disease. The aging process is highly
variable, and some aged individuals develop non-degenerative cognitive impairment while others
are resilient. The biological basis of this heterogeneity is unknown. However, aging is associated
with biochemical and morphological changes that may shed insight into the both the phenotypic
heterogeneity in aging and the age-related susceptibility to AD. In particular, changes in
hippocampal structure and connectivity are associated with aging. Among these changes is a
decline in neurogenesis in the dentate gyrus (DG) with decreased performance on hippocampus-
dependent cognitive tasks. BMP signaling in the brain increases dramatically with age, and we
have been exploring the hypothesis that this underlies aging-related changes neurogenesis and
cognition. BMP signaling and neurogenesis are also both altered significantly in AD. However, it
is unclear whether changes in BMP signaling and in neurogenesis in AD are an exacerbation of
the aging process or rather due to unrelated mechanisms. The goal of this proposed supplement
is to use both the knowledge and the tools developed as part of our ongoing studies of the role of
BMP signaling in the aging brain to define the role of this signaling pathway in the development
of AD. Second to age, the human apolipoprotein E (hAPOE) genotype is the strongest known risk
factor for sAD. Further, in aging mice, neuronal expression of the ε4 isoform results in neuron
loss and impaired learning and memory, and APOE regulates hippocampal neurogenesis. The
convergence of the effects of the aging related increase in BMP signaling and of APOE on
cognition and on neurogenesis suggest possible interactions between the aging related increase
in BMP signaling, APOE genotype, and the development of sAD. Specifically, we hypothesize
that the aging related increase in BMP signaling in brain predisposes neurons to the effects of
APOE4 and to development of AD, and that that it explains, at least in part, why aging is the
greatest risk factor for sAD. We will use the iPSC lines we derived from sAD patients to explore
interactions between APOE genotype and BMP signaling on tau phosphorylation, amyloid ß
secretion, and neurite preservation, and on neuronal survival after increasing calcium influx in
neurons derived from the iPSCs. We also will examine the role of BMP signaling in development
of pathology and of behavioral changes in 5XFAD mice.
衰老是发生散发性阿尔茨海默病 (sAD) 的主要危险因素,这表明
衰老过程与疾病的病理生理学有关。
变量,一些老年人出现非退行性认知障碍,而另一些人则出现非退行性认知障碍
这种异质性的生物学基础尚不清楚,但与衰老有关。
生化和形态学的变化可能有助于深入了解表型
衰老的异质性和与年龄相关的 AD 易感性,特别是 AD 的变化。
海马结构和连接性与衰老有关。
齿状回(DG)神经发生下降,海马体表现下降
大脑中依赖的 BMP 信号随着年龄的增长而急剧增加,而且我们
一直在探索这一假设,即这是与衰老相关的神经发生变化的基础,
然而,AD 中的 BMP 信号传导和神经发生也发生了显着改变。
目前尚不清楚 AD 中 BMP 信号传导和神经发生的变化是否会加剧
衰老过程或更确切地说是由于不相关的机制。本提议补充的目标。
是利用我们持续研究的一部分所开发的知识和工具
衰老大脑中的 BMP 信号传导确定了该信号传导途径在发育中的作用
除了年龄之外,人类载脂蛋白 E (hAPOE) 基因型是已知的最强的 AD 风险。
此外,在衰老小鼠中,ε4亚型的神经表达导致神经元的形成。
APOE 调节海马神经发生。
与衰老相关的 BMP 信号传导和 APOE 增加的影响趋同
认知和神经发生表明衰老相关增加之间可能存在相互作用
BMP 信号传导、APOE 基因型和 sAD 的发展。
大脑中与衰老相关的 BMP 信号传导增加使神经元容易受到
APOE4 与 AD 的发展有关,并且它至少部分地解释了为什么衰老是
我们将使用从 SAD 患者身上获得的 iPSC 系来探索。
APOE 基因型和 BMP 信号在 tau 磷酸化、淀粉样蛋白 ß 上的相互作用
分泌、神经突保存以及增加钙流入后的神经元存活
我们还将研究 BMP 信号传导在发育中的作用。
5XFAD 小鼠的病理学和行为变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN A KESSLER其他文献
JOHN A KESSLER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN A KESSLER', 18)}}的其他基金
Regulation of Hippocampal Neurogenesis and Behavior by Noggin
Noggin 对海马神经发生和行为的调节
- 批准号:
10655940 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Immune-modifying nanoparticles for the treatment of traumatic brain injury
用于治疗创伤性脑损伤的免疫调节纳米颗粒
- 批准号:
10404562 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Immune-modifying nanoparticles for the treatment of traumatic brain injury
用于治疗创伤性脑损伤的免疫调节纳米颗粒
- 批准号:
10219368 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Immune-modifying nanoparticles for the treatment of traumatic brain injury
用于治疗创伤性脑损伤的免疫调节纳米颗粒
- 批准号:
10027888 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
Immune-modifying nanoparticles for the treatment of traumatic brain injury
用于治疗创伤性脑损伤的免疫调节纳米颗粒
- 批准号:
10616537 - 财政年份:2020
- 资助金额:
$ 35.98万 - 项目类别:
BMP Signaling and Neurogenesis in Major Depressive Order
重度抑郁症中的 BMP 信号转导和神经发生
- 批准号:
10559642 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
BMP Signaling and Neurogenesis in Major Depressive Order
重度抑郁症中的 BMP 信号转导和神经发生
- 批准号:
10094255 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
BMP Signaling and Neurogenesis in Major Depressive Order
重度抑郁症中的 BMP 信号转导和神经发生
- 批准号:
10343695 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
BMP Signaling and Neurogenesis in Major Depressive Order
重度抑郁症中的 BMP 信号转导和神经发生
- 批准号:
9903466 - 财政年份:2019
- 资助金额:
$ 35.98万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
The role of complement in chronic neuroinflammation and cognitive decline after closed head brain injury
补体在闭合性脑损伤后慢性神经炎症和认知能力下降中的作用
- 批准号:
10641096 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Miniaturized AD/ADRD Microphysiological Systems Platform for High-throughput Screening
用于高通量筛选的小型化 AD/ADRD 微生理系统平台
- 批准号:
10761587 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Investigating whole-body innate immune activation in Alzheimer's disease using PET imaging and immune profiling
使用 PET 成像和免疫分析研究阿尔茨海默病的全身先天免疫激活
- 批准号:
10749393 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Machine Learning Approaches for Behavioral Phenotyping of Humanized Knock-in Models of Alzheimer's Disease
用于阿尔茨海默病人源化敲入模型行为表型的机器学习方法
- 批准号:
10741685 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Development of a novel, regenerative therapy to reverse synapse loss in Alzheimer's Disease
开发一种新颖的再生疗法来逆转阿尔茨海默氏病的突触损失
- 批准号:
10707700 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别: